Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating chemotherapy plus peripheral stem cell transplantation with or without rituximab for relapsed Non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Rituxan (rituximab)

Snippet

Sponsor: EBMT Solid Tumors Working Party | Conditions: Lymphoma | Phase 3 | Status: COMPLETED